The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
Open accessAbstract
Neuromyelitis optica (NMO) is an inflammatory demyelinating disease that typically affects optic nerves and spinal cord. Its pathogenic relationship to multiple sclerosis (MS) is uncertain. Unlike MS, NMO lesions are characterized by deposits of IgG and IgM co-localizing with products of complement activation in a vasculocentric pattern around thickened hyalinized blood vessels, suggesting a pathogenic role for humoral immunity targeting an antigen in the perivascular space. A recently identified specific serum autoantibody biomarker, NMO-IgG, targets aquaporin-4 (AQP4), the most abundant water channel protein in the CNS, which is highly concentrated in astrocytic foot processes. We analysed and compared patterns of AQP4 immunoreactivity in CNS tissues of nine patients with NMO, 13 with MS, nine with infarcts and five normal controls. In normal brain, optic nerve and spinal cord, the distribution of AQP4 expression resembles the vasculocentric pattern of immune complex deposition observed in NMO lesions. In contrast to MS lesions, which exhibit stage-dependent loss of AQP4, all NMO lesions demonstrate a striking loss of AQP4 regardless of the stage of demyelinating activity, extent of tissue necrosis, or site of CNS involvement. We identified a novel NMO lesion in the spinal cord and medullary tegmentum extending into the area postrema, characterized by AQP4 loss in foci that were inflammatory and oedematous, but neither demyelinated nor necrotic. Foci of AQP4 loss coincided with sites of intense vasculocentric immune complex deposition. These findings strongly support a role for a complement activating AQP4-specific autoantibody as the initiator of the NMO lesion, and further distinguish NMO from MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239 · cited 6×
“Lennon et al. subsequently identified a specific marker autoantibody (NMO-IgG), which interacts selectively with the AQP4 water channel (Lennon et al., 2005).”
BackgroundInfluentialSelf-citationRevised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
Self-citationIgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
Self-citationThe clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. F., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,822
Self-citationProtoplasmic Astrocytes in CA1 Stratum Radiatum Occupy Separate Anatomical Domains
Bushong, E. A., Martone, M. E., Jones, Y. Z., & Ellisman, M. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00183.2002 · Cited by 1,578
Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke
Manley, G. T., Fujimura, M., Ma, T., Noshita, N., Filiz, F., Bollen, A. W., Chan, P., & Verkman, A. S. (2000) · Nature Medicine · doi:10.1038/72256 · Cited by 1,507
Nielsen, S., Arnulf Nagelhus, E., Amiry-Moghaddam, M., Bourque, C., Agre, P., & Petter Ottersen, O. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00171.1997 · Cited by 1,442
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
Self-citationThe molecular basis of water transport in the brain
Amiry-Moghaddam, M., & Ottersen, O. P. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1252 · Cited by 733
Jung, J. S., Bhat, R. V., Preston, G. M., Guggino, W. B., Baraban, J. M., & Agre, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.13052 · Cited by 716
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
Self-citationAstrocyte barriers to neurotoxic inflammation
Sofroniew, M. V. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3898 · Cited by 1,202
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Self-citationOligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933
Self-citationA Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
Magliozzi, R., Howell, O. W., Reeves, C., Roncaroli, F., Nicholas, R., Serafini, B., Aloisi, F., & Reynolds, R. (2010) · Annals of Neurology · doi:10.1002/ana.22230 · Cited by 747
Frischer, J. M., Weigand, S. D., Guo, Y., Kale, N., Parisi, J. E., Pirko, I., Mandrekar, J., Bramow, S., Metz, I., Brück, W., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24497 · Cited by 728
Self-citationMyelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Sofroniew, M. V. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020420 · Cited by 695
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633
Neuromyelitis Optica and Non–Organ-Specific Autoimmunity
Pittock, S. J., Lennon, V. A., de Seze, J., Vermersch, P., Homburger, H. A., Wingerchuk, D. M., Lucchinetti, C. F., Zéphir, H., Moder, K., & Weinshenker, B. G. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.17 · Cited by 608
Self-citationAquaporin 4 and neuromyelitis optica
Papadopoulos, M. C., & Verkman, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70133-3 · Cited by 597
Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica
Bennett, J. L., Lam, C., Kalluri, S. R., Saikali, P., Bautista, K., Dupree, C., Glogowska, M., Case, D., Antel, J. P., Owens, G. P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21802 · Cited by 590
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., Adzemovic, M., Bauer, J., Berger, T., Fujihara, K., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21837 · Cited by 563
Self-citationSaadoun, S., Waters, P., Bell, B. A., Vincent, A., Verkman, A. S., & Papadopoulos, M. C. (2010) · Brain · doi:10.1093/brain/awp309 · Cited by 548
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
Hinson, S. R., Pittock, S. J., Lucchinetti, C. F., Roemer, S. F., Fryer, J. P., Kryzer, T. J., & Lennon, V. A. (2007) · Neurology · doi:10.1212/01.wnl.0000289761.64862.ce · Cited by 494
Self-citationJarius, S., Paul, F., Weinshenker, B. G., Levy, M., Kim, H. J., & Wildemann, B. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0214-9 · Cited by 478
Self-citationChihara, N., Aranami, T., Sato, W., Miyazaki, Y., Miyake, S., Okamoto, T., Ogawa, M., Toda, T., & Yamamura, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017385108 · Cited by 474
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
Jarius, S., Aboul-Enein, F., Waters, P., Kuenz, B., Hauser, A., Berger, T., Lang, W., Reindl, M., Vincent, A., & Kristoferitsch, W. (2008) · Brain · doi:10.1093/brain/awn240 · Cited by 435
Astrocytes in human central nervous system diseases: a frontier for new therapies
Verkhratsky, A., Butt, A., Li, B., Illes, P., Zorec, R., Semyanov, A., Tang, Y., & Sofroniew, M. V. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01628-9 · Cited by 428
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Jarius, S., & Wildemann, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.72 · Cited by 423
The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica
Lucchinetti, C. F., Guo, Y., Popescu, B. F. G., Fujihara, K., Itoyama, Y., & Misu, T. (2014) · Brain Pathology · doi:10.1111/bpa.12099 · Cited by 414
Self-citationPathology of Demyelinating Diseases
Popescu, B. F. G., & Lucchinetti, C. F. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132443 · Cited by 397
Self-citationPittock, S. J., Lennon, V. A., McKeon, A., Mandrekar, J., Weinshenker, B. G., Lucchinetti, C. F., O'Toole, O., & Wingerchuk, D. M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70076-0 · Cited by 395
Self-citationPittock, S. J., Debruyne, J., Krecke, K. N., Giannini, C., van den Ameele, J., De Herdt, V., McKeon, A., Fealey, R. D., Weinshenker, B. G., Aksamit, A. J., et al. (2010) · Brain · doi:10.1093/brain/awq164 · Cited by 371
Self-citationReactive Astrocytes As Therapeutic Targets for CNS Disorders
Hamby, M. E., & Sofroniew, M. V. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.003 · Cited by 365
Hinson, S. R., Roemer, S. F., Lucchinetti, C. F., Fryer, J. P., Kryzer, T. J., Chamberlain, J. L., Howe, C. L., Pittock, S. J., & Lennon, V. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081241 · Cited by 355
Self-citationPotassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
Srivastava, R., Aslam, M., Kalluri, S. R., Schirmer, L., Buck, D., Tackenberg, B., Rothhammer, V., Chan, A., Gold, R., Berthele, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110740 · Cited by 343
Simon, M. J., & Iliff, J. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.014 · Cited by 342
Neuromyelitis optica: clinical features, immunopathogenesis and treatment
Jarius, S., Wildemann, B., & Paul, F. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12271 · Cited by 342
Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica
Jarius, S., Paul, F., Franciotta, D., Waters, P., Zipp, F., Hohlfeld, R., Vincent, A., & Wildemann, B. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0764 · Cited by 335
Multiple Roles for Astrocytes as Effectors of Cytokines and Inflammatory Mediators
Sofroniew, M. V. (2014) · The Neuroscientist · doi:10.1177/1073858413504466 · Cited by 333
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
Hinson, S. R., Romero, M. F., Popescu, B. F. G., Lucchinetti, C. F., Fryer, J. P., Wolburg, H., Fallier-Becker, P., Noell, S., & Lennon, V. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109980108 · Cited by 328
Self-citationCytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6
Uzawa, A., Mori, M., Arai, K., Sato, Y., Hayakawa, S., Masuda, S., Taniguchi, J., & Kuwabara, S. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510379247 · Cited by 323
CNS aquaporin-4 autoimmunity in children
McKeon, A., Lennon, V. A., Lotze, T., Tenenbaum, S., Ness, J. M., Rensel, M., Kuntz, N. L., Fryer, J. P., Homburger, H., Hunter, J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000314832.24682.c6 · Cited by 322
Self-citationNeuromyelitis optica unique area postrema lesions: Nausea, vomiting, and pathogenic implications
Popescu, B. F. G., Lennon, V. A., Parisi, J. E., Howe, C. L., Weigand, S. D., Cabrera-Gómez, J. A., Newell, K., Mandler, R. N., Pittock, S. J., Weinshenker, B. G., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318214332c · Cited by 296
Self-citationAquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis
Waters, P., Jarius, S., Littleton, E., Leite, M. I., Jacob, S., Gray, B., Geraldes, R., Vale, T., Jacob, A., Palace, J., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.7.913 · Cited by 294
Neurodegeneration in multiple sclerosis and neuromyelitis optica
Kawachi, I., & Lassmann, H. (2017) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-313300 · Cited by 283
Self-citationThe history of neuromyelitis optica
Jarius, S., & Wildemann, B. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-8 · Cited by 279
Inflammation, demyelination, and degeneration — Recent insights from MS pathology
Stadelmann, C., Wegner, C., & Brück, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.007 · Cited by 276
Self-citationNeuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders
Banwell, B., Tenembaum, S., Lennon, V. A., Ursell, E., Kennedy, J., Bar-Or, A., Weinshenker, B. G., Lucchinetti, C. F., & Pittock, S. J. (2008) · Neurology · doi:10.1212/01.wnl.0000284600.80782.d5 · Cited by 263
Self-citationPathology of Multiple Sclerosis: Where Do We Stand?
Popescu, B. F. G., Pirko, I., & Lucchinetti, C. F. (2013) · Continuum · doi:10.1212/01.con.0000433291.23091.65 · Cited by 261
Self-citationThe astrocyte in multiple sclerosis revisited
Brosnan, C. F., & Raine, C. S. (2013) · Glia · doi:10.1002/glia.22443 · Cited by 259
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
Bennett, J., de Seze, J., Lana-Peixoto, M., Palace, J., Waldman, A., Schippling, S., Tenembaum, S., Banwell, B., Greenberg, B., Levy, M., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514567216 · Cited by 252
A neurodegenerative perspective on mitochondrial optic neuropathies
Yu-Wai-Man, P., Votruba, M., Burté, F., La Morgia, C., Barboni, P., & Carelli, V. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1625-2 · Cited by 176
“After decades of debate, clinicopathological studies have revealed striking differences between NMO and prototypic MS firmly establishing the two of them as distinct disease entities [23, 95, 113].”
ResultAtypical inflammatory demyelinating syndromes of the CNS
Hardy, T. A., Reddel, S. W., Barnett, M. H., Palace, J., Lucchinetti, C. F., & Weinshenker, B. G. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30043-6 · Cited by 161
Self-citationThe clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes
Sellner, J., Hemmer, B., & Mühlau, M. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.013 · Cited by 142
Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model
Berghoff, S. A., Düking, T., Spieth, L., Winchenbach, J., Stumpf, S. K., Gerndt, N., Kusch, K., Ruhwedel, T., Möbius, W., & Saher, G. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0497-6 · Cited by 100
“Paracellular influx of fluid because of BBB disruption is the leading cause of vasogenic edema [54], also found in MS and inflammatory models of MS [9, 48, 60].”
Pathogenic T cell responses against aquaporin 4
Pohl, M., Fischer, M.-T., Mader, S., Schanda, K., Kitic, M., Sharma, R., Wimmer, I., Misu, T., Fujihara, K., Reindl, M., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0824-0 · Cited by 98
Self-citationImmunology of neuromyelitis optica: a T cell-B cell collaboration
Mitsdoerffer, M., Kuchroo, V., & Korn, T. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12118 · Cited by 91
Linhares, U. C., Schiavoni, P. B., Barros, P. O., Kasahara, T. M., Teixeira, B., Ferreira, T. B., Alvarenga, R., Hygino, J., Vieira, M. M. M., Bittencourt, V. C. B., et al. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9780-2 · Cited by 78
Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica
Tradtrantip, L., Yao, X., Su, T., Smith, A. J., & Verkman, A. S. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1734-6 · Cited by 65
Reactive Astrocytes and Emerging Roles in Central Nervous System (CNS) Disorders
Liddelow, S. A., Olsen, M. L., & Sofroniew, M. V. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041356 · Cited by 55
MicroRNA expression patterns in human astrocytes in relation to anatomical location and age.
Rao, V. T. S., Ludwin, S. K., Fuh, S.-C., Sawaya, R., Moore, C. S., Ho, M.-K., Bedell, B. J., Sarnat, H. B., Bar-Or, A., & Antel, J. P. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv016 · Cited by 50
“The lower expression of miR-320, a negative regulator of aquaporin-4 (28), may account for the very prominent staining of this protein in the glial limitans (29).”
BackgroundOlfactory Pathology in Central Nervous System Demyelinating Diseases
DeLuca, G. C., Joseph, A., George, J., Yates, R. L., Hamard, M., Hofer, M., & Esiri, M. M. (2015) · Brain Pathology · doi:10.1111/bpa.12209 · Cited by 46
Neuromyelitis optica and neuromyelitis optica spectrum disorders
Marignier, R., Cobo Calvo, A., & Vukusic, S. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000455 · Cited by 45
Aquaporin 4 molecular mimicry and implications for neuromyelitis optica
Vaishnav, R. A., Liu, R., Chapman, J., Roberts, A. M., Ye, H., Rebolledo-Mendez, J. D., Tabira, T., Fitzpatrick, A. H., Achiron, A., Running, M. P., et al. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.04.015 · Cited by 36
Yick, L.-W., Ma, O. K.-F., Chan, E. Y.-Y., Yau, K. X., Kwan, J. S.-C., & Chan, K.-H. (2023) · JCI Insight · doi:10.1172/jci.insight.161003 · Cited by 21
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
Liu, Y., Harlow, D. E., Given, K. S., Owens, G. P., Macklin, W. B., & Bennett, J. L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0767-4 · Cited by 17
Lin, T.-Y., Chien, C., Lu, A., Paul, F., & Zimmermann, H. G. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1982697 · Cited by 16
Metadata
- Authors
- Roemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., & Lucchinetti, C. F.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-02
- Volume
- 130
- Issue
- 5
- Pages
- 1194-1205
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2009308901
- Cited by
- 716
- References
- 36
- FWCI
- 36.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.